Clinical Trial Update: Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating fecal microbiota transplantation to prevent toxicity in renal cell carcinoma patients treated with immunotherapy; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Renal Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING